TU‐C‐BRB‐04: A Monte Carlo‐Based Small Animal Dosimetry Platform for Pre‐Clinical Trials: Proof of Concept

B. Bednarz, A. Besemer, Y. Yang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The development of novel agents for targeted radionuclide therapy has led to an important need for accurate dosimetry characterization during pre‐clinical trials. The purpose of this study is to discuss our progress in developing a fully automated Monte Carlo‐based dosimetry platform for external and/or internal absorbed dose quantification in small animals. Methods: The dosimetry platform was built entirely around the Monte Carlo code Geant4 version 9.3. CT and PET image datasets of a mouse injected with CLR1404, a novel tumor target pharmaceutical that is tagged with both I‐124 and I‐131 for imaging and therapy, were used for this preliminary study. The activity distribution in the tumor acquired from the PET scan was modeled as a simple spherical source. The same CT image set was used to generate external dose distributions from a 6 MV photon beam spectrum. Results: The external dose distributions from the 6 MV photon source and the internal dose distributions from CLR1404 were combined to get a relative dose distribution within the mouse. Conclusions: We provided a proof‐of‐concept for a fully automated dose calculation platform in small animals that can be used for developing protocols for pre‐clinical trials. We are currently working on additional modifications to better represent both the external beam source for our small animal irradiator as well as the activity distributions gathered by the PET scan.

Original languageEnglish (US)
Number of pages1
JournalMedical physics
Volume39
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Photons
Positron-Emission Tomography
Clinical Protocols
Radioisotopes
Neoplasms
Therapeutics
Pharmaceutical Preparations
CLR1404
Datasets
Positron Emission Tomography Computed Tomography

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

TU‐C‐BRB‐04 : A Monte Carlo‐Based Small Animal Dosimetry Platform for Pre‐Clinical Trials: Proof of Concept. / Bednarz, B.; Besemer, A.; Yang, Y.

In: Medical physics, Vol. 39, No. 6, 06.2012.

Research output: Contribution to journalArticle

@article{9558460c4a0048759aa0e7ca5d382bfe,
title = "TU‐C‐BRB‐04: A Monte Carlo‐Based Small Animal Dosimetry Platform for Pre‐Clinical Trials: Proof of Concept",
abstract = "Purpose: The development of novel agents for targeted radionuclide therapy has led to an important need for accurate dosimetry characterization during pre‐clinical trials. The purpose of this study is to discuss our progress in developing a fully automated Monte Carlo‐based dosimetry platform for external and/or internal absorbed dose quantification in small animals. Methods: The dosimetry platform was built entirely around the Monte Carlo code Geant4 version 9.3. CT and PET image datasets of a mouse injected with CLR1404, a novel tumor target pharmaceutical that is tagged with both I‐124 and I‐131 for imaging and therapy, were used for this preliminary study. The activity distribution in the tumor acquired from the PET scan was modeled as a simple spherical source. The same CT image set was used to generate external dose distributions from a 6 MV photon beam spectrum. Results: The external dose distributions from the 6 MV photon source and the internal dose distributions from CLR1404 were combined to get a relative dose distribution within the mouse. Conclusions: We provided a proof‐of‐concept for a fully automated dose calculation platform in small animals that can be used for developing protocols for pre‐clinical trials. We are currently working on additional modifications to better represent both the external beam source for our small animal irradiator as well as the activity distributions gathered by the PET scan.",
author = "B. Bednarz and A. Besemer and Y. Yang",
year = "2012",
month = "6",
doi = "10.1118/1.4735916",
language = "English (US)",
volume = "39",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - TU‐C‐BRB‐04

T2 - A Monte Carlo‐Based Small Animal Dosimetry Platform for Pre‐Clinical Trials: Proof of Concept

AU - Bednarz, B.

AU - Besemer, A.

AU - Yang, Y.

PY - 2012/6

Y1 - 2012/6

N2 - Purpose: The development of novel agents for targeted radionuclide therapy has led to an important need for accurate dosimetry characterization during pre‐clinical trials. The purpose of this study is to discuss our progress in developing a fully automated Monte Carlo‐based dosimetry platform for external and/or internal absorbed dose quantification in small animals. Methods: The dosimetry platform was built entirely around the Monte Carlo code Geant4 version 9.3. CT and PET image datasets of a mouse injected with CLR1404, a novel tumor target pharmaceutical that is tagged with both I‐124 and I‐131 for imaging and therapy, were used for this preliminary study. The activity distribution in the tumor acquired from the PET scan was modeled as a simple spherical source. The same CT image set was used to generate external dose distributions from a 6 MV photon beam spectrum. Results: The external dose distributions from the 6 MV photon source and the internal dose distributions from CLR1404 were combined to get a relative dose distribution within the mouse. Conclusions: We provided a proof‐of‐concept for a fully automated dose calculation platform in small animals that can be used for developing protocols for pre‐clinical trials. We are currently working on additional modifications to better represent both the external beam source for our small animal irradiator as well as the activity distributions gathered by the PET scan.

AB - Purpose: The development of novel agents for targeted radionuclide therapy has led to an important need for accurate dosimetry characterization during pre‐clinical trials. The purpose of this study is to discuss our progress in developing a fully automated Monte Carlo‐based dosimetry platform for external and/or internal absorbed dose quantification in small animals. Methods: The dosimetry platform was built entirely around the Monte Carlo code Geant4 version 9.3. CT and PET image datasets of a mouse injected with CLR1404, a novel tumor target pharmaceutical that is tagged with both I‐124 and I‐131 for imaging and therapy, were used for this preliminary study. The activity distribution in the tumor acquired from the PET scan was modeled as a simple spherical source. The same CT image set was used to generate external dose distributions from a 6 MV photon beam spectrum. Results: The external dose distributions from the 6 MV photon source and the internal dose distributions from CLR1404 were combined to get a relative dose distribution within the mouse. Conclusions: We provided a proof‐of‐concept for a fully automated dose calculation platform in small animals that can be used for developing protocols for pre‐clinical trials. We are currently working on additional modifications to better represent both the external beam source for our small animal irradiator as well as the activity distributions gathered by the PET scan.

UR - http://www.scopus.com/inward/record.url?scp=84944168844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944168844&partnerID=8YFLogxK

U2 - 10.1118/1.4735916

DO - 10.1118/1.4735916

M3 - Article

AN - SCOPUS:84944168844

VL - 39

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -